Ind-Swift Laboratories: Price & volume buzzer

Ind-Swift Laboratories is one of the buzzing stocks on the bourses in today’s session. The stock is trading up by 12 per cent and also, registered a fresh 52-week high. The 20-day average volume of the stock stands at 3.78 lakh, whereas today’s volume in the first half of the trading session stands over 13 lakh. A massive jump in price backed with robust volume indicates buying interest in the stock.   

Ind-Swift Laboratories Ltd is a significant player in manufacturing APIs towards cardiovascular health, antihistamine, antidiabetic, antipsychotic, antimigraine, Parkinson’s disease, antineoplastic, ADHD symptoms, analgesics, alcohol abstinence, and bone resorption inhibitor. The company also holds global leadership positions in Macrolide antibiotics segment.  

Meanwhile, the stock gained nearly 57 per cent on a YTD basis and it is up by nearly 18 per cent on an MTD basis.   

The promoters’ holding remains unchanged at 42 per cent in March 2021 quarter while the promoters’ pledge remained unchanged at 86.87 per cent of holding in March 2021 quarter.